These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 17965748)
1. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. Chin CL; Tovcimak AE; Hradil VP; Seifert TR; Hollingsworth PR; Chandran P; Zhu CZ; Gauvin D; Pai M; Wetter J; Hsieh GC; Honore P; Frost JM; Dart MJ; Meyer MD; Yao BB; Cox BF; Fox GB Br J Pharmacol; 2008 Jan; 153(2):367-79. PubMed ID: 17965748 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models. Yao BB; Hsieh GC; Frost JM; Fan Y; Garrison TR; Daza AV; Grayson GK; Zhu CZ; Pai M; Chandran P; Salyers AK; Wensink EJ; Honore P; Sullivan JP; Dart MJ; Meyer MD Br J Pharmacol; 2008 Jan; 153(2):390-401. PubMed ID: 17994110 [TBL] [Abstract][Full Text] [Related]
3. Opposite effects of cannabinoid CB Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759 [TBL] [Abstract][Full Text] [Related]
4. Opposing roles of CB Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain. Xu JJ; Diaz P; Astruc-Diaz F; Craig S; Munoz E; Naguib M Anesth Analg; 2010 Jul; 111(1):99-109. PubMed ID: 20522703 [TBL] [Abstract][Full Text] [Related]
6. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats. Calik MW; Carley DW Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490 [TBL] [Abstract][Full Text] [Related]
8. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Rahn EJ; Makriyannis A; Hohmann AG Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats. Calik MW; Carley DW PLoS One; 2014; 9(10):e111412. PubMed ID: 25350456 [TBL] [Abstract][Full Text] [Related]
11. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy. Barnes RC; Blanton H; Dancel CL; Castro-Piedras I; Rorabaugh BR; Morgan DJ; Guindon J J Pharmacol Exp Ther; 2024 Oct; 391(2):258-271. PubMed ID: 38936979 [TBL] [Abstract][Full Text] [Related]
12. CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain. Khasabova IA; Gielissen J; Chandiramani A; Harding-Rose C; Odeh DA; Simone DA; Seybold VS Behav Pharmacol; 2011 Sep; 22(5-6):607-16. PubMed ID: 21610490 [TBL] [Abstract][Full Text] [Related]
13. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation. Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats. Delis F; Polissidis A; Poulia N; Justinova Z; Nomikos GG; Goldberg SR; Antoniou K Int J Neuropsychopharmacol; 2017 Mar; 20(3):269-278. PubMed ID: 27994006 [TBL] [Abstract][Full Text] [Related]
15. Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain. Li MH; Suchland KL; Ingram SL J Neurosci; 2017 Jan; 37(3):626-636. PubMed ID: 28100744 [TBL] [Abstract][Full Text] [Related]
17. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Ibrahim MM; Deng H; Zvonok A; Cockayne DA; Kwan J; Mata HP; Vanderah TW; Lai J; Porreca F; Makriyannis A; Malan TP Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10529-33. PubMed ID: 12917492 [TBL] [Abstract][Full Text] [Related]
18. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363 [TBL] [Abstract][Full Text] [Related]
19. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system. Romero TR; Resende LC; Guzzo LS; Duarte ID Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980 [TBL] [Abstract][Full Text] [Related]
20. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]